AU560922B2 – Four phase administration of estrogen and progesteron
– Google Patents
AU560922B2 – Four phase administration of estrogen and progesteron
– Google Patents
Four phase administration of estrogen and progesteron
Info
Publication number
AU560922B2
AU560922B2
AU86976/82A
AU8697682A
AU560922B2
AU 560922 B2
AU560922 B2
AU 560922B2
AU 86976/82 A
AU86976/82 A
AU 86976/82A
AU 8697682 A
AU8697682 A
AU 8697682A
AU 560922 B2
AU560922 B2
AU 560922B2
Authority
AU
Australia
Prior art keywords
progesteron
estrogen
phase administration
administration
phase
Prior art date
1981-08-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU86976/82A
Other versions
AU8697682A
(en
Inventor
Richard Arthur Edgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1981-08-10
Filing date
1982-08-09
Publication date
1987-04-30
1982-08-09
Application filed by Syntex USA LLC
filed
Critical
Syntex USA LLC
1983-02-17
Publication of AU8697682A
publication
Critical
patent/AU8697682A/en
1987-04-30
Application granted
granted
Critical
1987-04-30
Publication of AU560922B2
publication
Critical
patent/AU560922B2/en
2002-08-09
Anticipated expiration
legal-status
Critical
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
AU86976/82A
1981-08-10
1982-08-09
Four phase administration of estrogen and progesteron
Expired
AU560922B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US06/291,533
US4390531A
(en)
1981-08-10
1981-08-10
Method of contraception using peak progestogen dosage
US291533
1981-08-10
Publications (2)
Publication Number
Publication Date
AU8697682A
AU8697682A
(en)
1983-02-17
AU560922B2
true
AU560922B2
(en)
1987-04-30
Family
ID=23120688
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU86976/82A
Expired
AU560922B2
(en)
1981-08-10
1982-08-09
Four phase administration of estrogen and progesteron
Country Status (9)
Country
Link
US
(1)
US4390531A
(en)
AU
(1)
AU560922B2
(en)
CA
(1)
CA1198057A
(en)
DE
(1)
DE3229612A1
(en)
GB
(1)
GB2104779B
(en)
HK
(1)
HK26087A
(en)
MY
(1)
MY8700596A
(en)
NZ
(1)
NZ201539A
(en)
SG
(1)
SG93686G
(en)
Families Citing this family (54)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4962098A
(en)
*
1987-06-15
1990-10-09
Warner-Lambert Company
Graduated estrogen contraceptive
US5010070A
(en)
*
1987-06-15
1991-04-23
Warner-Lambert Company
Graduated estrogen contraceptive
US5208225A
(en)
*
1986-02-27
1993-05-04
Warner-Lambert Company
Compositions containing fixed combinations
US4958736A
(en)
*
1986-03-18
1990-09-25
Gynex, Inc.
Package for oral contraceptive tablet
US4855305A
(en)
*
1987-03-23
1989-08-08
Applied Medical Research
Compositions and methods of effecting contraception utilizing melatonin
US5108995A
(en)
*
1987-09-24
1992-04-28
Jencap Research Ltd.
Hormone preparation and method
US5276022A
(en)
*
1987-09-24
1994-01-04
Jencap Research Ltd.
Hormone preparation and method
US4945103A
(en)
*
1989-01-17
1990-07-31
Michael Cohen
Method of treating pre-menstrual syndrome
DE4308406C1
(en)
*
1993-03-12
1994-06-16
Jenapharm Gmbh
Contraceptive compsn. with reduced hormone dose and reduced side-effects – contg. synergistic mixt. of biogenic, synthetic oestrogen and gestagen
DE4339934C2
(en)
*
1993-05-07
1995-05-24
Klaus Dr Med Umbreit
Anti-ovulation agent for hormonal contraception
US6407082B1
(en)
*
1996-09-13
2002-06-18
New Life Pharmaceuticals Inc.
Prevention of ovarian cancer by administration of a vitamin D compound
ZA949929B
(en)
*
1993-12-23
1995-08-23
Akzo Nobel Nv
Sugar-coated pharmaceutical dosage unit.
DE4429374C1
(en)
1994-08-12
1996-02-01
Jenapharm Gmbh
Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component
US5547948A
(en)
*
1995-01-17
1996-08-20
American Home Products Corporation
Controlled release of steroids from sugar coatings
US5759577A
(en)
*
1995-01-17
1998-06-02
American Home Products Corporation
Controlled release of steroids from sugar coatings
FR2737411B1
(en)
*
1995-08-01
1997-10-17
Theramex
NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19540253C2
(en)
*
1995-10-28
1998-06-04
Jenapharm Gmbh
Multi-phase preparation for contraception based on natural estrogens
US5747480A
(en)
*
1996-05-08
1998-05-05
American Home Products Corporation
Oral contraceptive
US6451778B1
(en)
1996-07-26
2002-09-17
Wyeth
Oral contraceptive
US6479475B1
(en)
1996-07-26
2002-11-12
Wyeth
Oral contraceptive
US5888543A
(en)
*
1996-07-26
1999-03-30
American Home Products Corporation
Oral contraceptives
US5858405A
(en)
*
1996-07-26
1999-01-12
American Home Products Corporation
Oral contraceptive
US6034074A
(en)
1996-09-13
2000-03-07
New Life Pharmaceuticals Inc.
Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2
(en)
2000-03-21
2004-07-20
Gustavo Rodriguez
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A
(en)
1996-09-13
2000-02-22
New Life Pharmaceuticals Inc.
Prevention of ovarian cancer by administration of progestin products
US6511970B1
(en)
1996-09-13
2003-01-28
New Life Pharmaceuticals Inc.
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
WO2001030355A1
(en)
1999-10-25
2001-05-03
Laboratoire Theramex
Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
FR2754179B1
(en)
1996-10-08
1998-12-24
Theramex
NOVEL HORMONONAL COMPOSITION AND ITS USE
US5898032A
(en)
*
1997-06-23
1999-04-27
Medical College Of Hampton Roads
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
ATE279198T1
(en)
*
1997-08-27
2004-10-15
Ortho Mcneil Pharm Inc
COMBINATIONS OF ENDOMETRUM-SPAREING PROGESTAGENS AND ENDOMETRUM ATROPHIZING PROGESTAGENS WITH ESTROGENS, IN ORAL CONTRACEPTION
US6251956B1
(en)
1998-08-20
2001-06-26
Ortho Pharmaceutical Corporation
Combination progestin oral contraceptive regimen
EP1148884A4
(en)
*
1998-11-12
2003-06-11
Warner Chilcott Lab Ireland Lt
Graduated progestin contraceptive
US20050038006A1
(en)
*
1998-12-23
2005-02-17
Shangold Gary A.
Triphasic oral contraceptive
US6214815B1
(en)
1998-12-23
2001-04-10
Ortho-Mcneil Pharmaceuticals, Inc.
Triphasic oral contraceptive
US6855703B1
(en)
2000-03-10
2005-02-15
Endeavor Pharmaceuticals
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2
(en)
2000-03-10
2003-12-09
Endeavor Pharmaceuticals
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2
(en)
*
2000-03-10
2008-12-02
Duramed Pharmaceuticals, Inc.
Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2
(en)
2003-07-23
2011-08-02
Duramed Pharmaceuticals, Inc.
Estrogenic compounds and pharmaceutical formulations comprising the same
US20050113351A1
(en)
*
2000-03-21
2005-05-26
Rodriguez Gustavo C.
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1
(en)
*
2000-03-21
2001-11-22
Rodriguez Gustavo C.
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1
(en)
*
2000-03-21
2004-09-09
Rodriguez Gustavo C.
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
CN101757628A
(en)
*
2001-12-05
2010-06-30
杜拉美德药物有限公司
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US6992075B2
(en)
*
2003-04-04
2006-01-31
Barr Laboratories, Inc.
C(14) estrogenic compounds
WO2004091535A2
(en)
*
2003-04-11
2004-10-28
Barr Laboratories, Inc.
Methods of administering estrogens and progestins
AU2004257772B2
(en)
*
2003-07-16
2009-12-17
Teva Women’s Health, Inc.
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP2295041A3
(en)
*
2003-09-29
2012-01-04
Novo Nordisk Femcare AG
HRT formulations
AU2004275470B2
(en)
*
2003-09-29
2010-12-02
Novo Nordisk Health Care Ag
Improved stability of progestogen formulations
JP2007507534A
(en)
*
2003-10-01
2007-03-29
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ
Sustained three-phase contraception
WO2005092441A2
(en)
*
2004-03-19
2005-10-06
Warner Chilcott Company, Inc.
Extended cycle multiphasic oral contraceptive method
DE102004019743B4
(en)
*
2004-04-20
2008-11-27
Bayer Schering Pharma Aktiengesellschaft
Multiphase preparation for contraception based on natural estrogen
US20070111975A1
(en)
*
2004-10-07
2007-05-17
Duramed Pharmaceuticals, Inc.
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20060183724A1
(en)
*
2005-02-03
2006-08-17
Diliberti Charles E
Compositions of unconjugated estrogens and methods for their use
US8153616B2
(en)
2005-10-17
2012-04-10
Bayer Pharma Aktiengesellschaft
Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1
(en)
*
2006-10-20
2008-06-11
Bayer Schering Pharma Aktiengesellschaft
Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido
Family Cites Families (18)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3568828A
(en)
*
1967-03-01
1971-03-09
Squibb & Sons Inc
Modified sequential oral contraceptive
GB1175468A
(en)
*
1967-10-19
1969-12-23
Merck Ag E
Pharmaceutical Compositions
US3639600A
(en)
*
1969-08-28
1972-02-01
Upjohn Co
Process of establishing cyclicity in a human female
US3795734A
(en)
*
1970-04-20
1974-03-05
American Home Prod
Cyclic regimen of hormone administration for contraception
US3733407A
(en)
*
1971-08-25
1973-05-15
Syntex Corp
Menopause treatment
US3836651A
(en)
*
1972-02-22
1974-09-17
Biolog Concepts Inc
Novel oral contraceptive combination
DE2218831C3
(en)
*
1972-04-14
1979-08-30
Schering Ag, 1000 Berlin Und 4619 Bergkamen
Use of hormones for contraception
DE2335265A1
(en)
*
1973-07-09
1975-01-30
Schering Ag
METHOD OF CONTRACTION BY FOLLOWING STAGE COMBINATION PREPARATIONS
IE38781B1
(en)
*
1973-02-13
1978-05-24
Ciba Geigy Ag
A medicament pack for the oral treatment with oestrogen
US4066757A
(en)
*
1973-03-26
1978-01-03
Ortho Pharmaceutical Corporation
Oral contraceptive regimen
DE2365103C3
(en)
*
1973-12-21
1980-08-28
Schering Ag, 1000 Berlin Und 4619 Bergkamen
Use of hormones for contraception
DE2431694A1
(en)
*
1974-07-02
1976-03-04
Asche Ag
Sequential, two-stage contraceptive agents – contg a gestagen in the first stage, a gestagen plus oestrogen in the second stage and opt complementary placeboss
DE2431704A1
(en)
*
1974-07-02
1976-01-22
Asche Ag
Three-stage combination oral contraceptives – contg. oestrogen with increasing doses of gestagen
US4018919A
(en)
*
1975-07-16
1977-04-19
Eli Lilly And Company
Sequential contraceptive method using two types of progestational agents
DE2645307A1
(en)
*
1976-10-05
1978-04-06
Schering Ag
NEW MEANS AND NEW METHODS FOR TREATING CLIMATE FAILURE
US4143136A
(en)
*
1976-11-20
1979-03-06
Akzona Incorporated
Method of contraception
US4292315A
(en)
*
1977-12-30
1981-09-29
Nichols Vorys
Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4425339A
(en)
*
1981-04-09
1984-01-10
Syntex (U.S.A.) Inc.
Treatment of menopausal symptoms
1981
1981-08-10
US
US06/291,533
patent/US4390531A/en
not_active
Expired – Lifetime
1982
1982-08-09
DE
DE19823229612
patent/DE3229612A1/en
active
Granted
1982-08-09
NZ
NZ201539A
patent/NZ201539A/en
unknown
1982-08-09
AU
AU86976/82A
patent/AU560922B2/en
not_active
Expired
1982-08-09
CA
CA000409011A
patent/CA1198057A/en
not_active
Expired
1982-08-09
GB
GB08222917A
patent/GB2104779B/en
not_active
Expired
1986
1986-12-09
SG
SG936/86A
patent/SG93686G/en
unknown
1987
1987-03-26
HK
HK260/87A
patent/HK26087A/en
not_active
IP Right Cessation
1987-12-30
MY
MY596/87A
patent/MY8700596A/en
unknown
Also Published As
Publication number
Publication date
GB2104779B
(en)
1984-08-15
GB2104779A
(en)
1983-03-16
US4390531A
(en)
1983-06-28
AU8697682A
(en)
1983-02-17
CA1198057A
(en)
1985-12-17
NZ201539A
(en)
1986-04-11
HK26087A
(en)
1987-04-03
DE3229612C2
(en)
1992-07-02
MY8700596A
(en)
1987-12-31
DE3229612A1
(en)
1983-02-24
SG93686G
(en)
1987-07-03
Similar Documents
Publication
Publication Date
Title
AU560922B2
(en)
1987-04-30
Four phase administration of estrogen and progesteron
AU3256189A
(en)
1989-08-03
Admixtures of steroids and drugs
AU551720B2
(en)
1986-05-08
Preparation of 3-hydroxy-ml-236b derivatives using nocardia
AU4952885A
(en)
1986-11-05
Lipsomes and compositions of sterol derivatives
NZ222103A
(en)
1990-08-28
9-alpha-hydroxy steroids and pharmaceutical preparations containing them
AU576313B2
(en)
1988-08-25
Preparation of liposomes and derivatives
AU546050B2
(en)
1985-08-15
Preparation of silicon
AU8015587A
(en)
1988-04-28
4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU6373286A
(en)
1987-03-24
Auto-anti-idiotypic monoclonal antibodies to steroid receptals and uses thereof
AU9122082A
(en)
1983-06-17
Pharmaceutical preparations and compositions
AU1501283A
(en)
1983-12-01
(n-substituted-piperazinyl) derivatives of imidazo- pyridines and pyrido-pyrazines
AU6733381A
(en)
1981-09-10
3-0-demethyl derivatives of sannamycin c and
AU575783B2
(en)
1988-08-11
14-amino steroid derivatives
AU567280B2
(en)
1987-11-12
Phase separating rotary processor and method
AU561033B2
(en)
1987-04-30
Xanthene derivatives and photographic use of
AU574852B2
(en)
1988-07-14
13 – acyloxy – 5 – ketomilbemycin derivatives and preparation of 13 – hydroxy – 5 – ketomilbemycin derivatives
AU524171B2
(en)
1982-09-02
Isomerisation of derivatives of 3-vinyl-piperidine
AU566251B2
(en)
1987-10-15
Antigenic preparations derived from bacteroides nodosus
AU3025184A
(en)
1985-01-10
Preparation of ethanol and/or ehtyl acetate
AU8652282A
(en)
1983-02-03
Preparation of 4-aminobutyramide
EP0148616A3
(en)
1986-05-07
Stabilised monolithium acetylide and the ethynylation of steroids
AU534122B2
(en)
1984-01-05
Preparation of hydroquinone
AU9170682A
(en)
1983-06-23
Preparation of 7-methyl-3-methylene-7-octen-1-yl propanoate
AU525047B2
(en)
1982-10-14
Preparation of lactosylurea and n-methylol-lactosylurea
AU5136879A
(en)
1980-05-01
Imidazolylethoxy derivatives of pyridin-5-methanols and quinoline-3-methanols
Legal Events
Date
Code
Title
Description
2003-03-13
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
